[ad_1]
Medical Express has published a report on the launch of self-examination clinical trials, in which molecules that can indicate early cancer are analyzed.
The report translated by "Arab"This test is the first of its kind to look for different types of cancer," he said.There are great opportunities to use this external examination to identify what is happening in the body and to help in the early diagnosis of cancer , where the probability of treatment is more effective.
The Cambridge Cancer Research Center conducts this experiment, which reveals different cancers, through a respiratory test, in cooperation with Olston Medical, which provides a self-examination technology. Respiratory samples are taken from volunteers during the experiment to examine the presence of molecules. The odor is called volatile organic compounds (VOCs).
"We need to urgently develop new tools, such as respiratory tests, that could help us detect and diagnose cancer earlier, which would give patients more chances of being diagnosed," said the professor. Rebecca Fitzgerald, who leads the research team at the Cambridge Cancer Research Center. Healing their disease ".
"We hope to discover through this clinical trial the fingerprints we need to detect cancers earlier," she said. "The next step is to develop this technology.Olston Medical is the first to look at several types of cancer, for a full breath test."
The site shows that when cells interact with biochemistry, as part of metabolic processes, they produce a group of volatile organic compounds and that, if the metabolism changes due to cancer and other symptoms, the cells produce another model of volatile organic compounds, pointing out that researchers identify different models using Olston Medical technology for self-sampling.
The report says that the experiment researchers will collect 1,500 samples of people, including healthy people, to control the analysis, analyzing the volatile organic respiratory compounds, to determine whether the detection of indicators of different types of cancer, stating that the clinical trial will begin with suspected patients that they have cancer of the esophagus or stomach they are 39, then address people who suspect prostate cancer, kidney, bladder, liver or pancreas in the months to come.
According to the website, testers are trying to recruit volunteers from the Edinburgh Hospital in Cambridge, transferred from their doctors, to suspect that they have been diagnosed with this type of cancer. These same samples will be examined before being subjected to further tests, while patients will breathe for 10 minutes into the device to take the sample, will be analyzed later at the Olston Medical Laboratory in Cambridge.
The study shows that by studying different types of cancer, this study will contribute to an in-depth analysis if different cancer indicators are similar or different, noting that some people will be diagnosed with cancer and that their samples will be compared to samples taken from people without cancer.
While technology can accurately detect cancer, its authors hope to transmit it to general practitioners, who will then decide to ask patients to undergo new tests.
"There are more and more opportunities for respiratory tests to aid diagnosis, blood and urine tests to help doctors detect and treat diseases, and the idea that they can be used to treat the condition. an external test would give a complete idea, "said co-founder and CEO of Olston Medical, Billy Boyle. The state of health of the whole body is a powerful idea that could help relieve the pain caused by other tests. "
"The technology we have demonstrated has proven effective for the discovery of volatile organic compounds and we are proud to be working with the British Society for Cancer Research," Boyle said. We hope to apply our results to an important aspect of the early detection of several cancers. Patients ".
About half of cancer cases are diagnosed late in England, highlighting the importance of early diagnosis, especially for diseases such as esophageal cancer, in which only 12% of patients live for at least 10 years.
According to the report, Nebricka Koldrick, 54, of Cambridge, was diagnosed in the 1930s with Barrett Barrett's disease, which affects the esophagus: the cells lining the esophagus turn into abnormal cells to because of acid reflux, which sometimes turns into cancer. Esophagus
"About 20 years ago, I became acidic, I was living on Javiscon and other antacids, I went to the doctor and I was quickly diagnosed with Barrett infection, and I have to undergo endoscopy of the esophagus every two years, "Rebecca said on the website. To monitor my case. "
The report shows that monitoring patients at high risk of cancer, such as esophageal cancer, usually requires painful operations for patients who do not necessarily develop the disease, noting that Rebecca has decided to participate in the Early detection of cancer by self-examination, an external examination of this sex can help in the future to identify the people most likely to have esophageal cancer and those who are less likely to develop the disease.
"I was happy to participate in the experiment and wanted to help in any way.In the beginning, I was afraid of feeling choked while wearing the mask, but that was not enough. was never produced … and I was examined quickly and painlessly and the tests were better developed, it was better. "
"Technology such as this self-examination could revolutionize how we diagnose cancer in the future," said Dr. David Crosby, head of early detection research at the UK Cancer Research Society.
"Research on early detection (cancer) has always faced a lack of funding and interest for the industry," he said. "This work is a shining example of the UK Cancer Society's commitment to reversing this trend to advance cancer diagnosis in its infancy."
"Recognizing the importance of early diagnosis to improve survival, the UK Cancer Research Association has conducted research on this aspect of its priorities and will invest more than £ 20 million a year in early childhood cancer research. 39, here 2019 ", concludes Medical Express. .
To read the original text, click here.
[ad_2]
Source link
